Concurrent Session 7C: Low dead-space needle and syringe scale-up and peer-led harm reduction: building prevention synergies in low- and middle-income countries
Tracks
Track 3
| Friday, October 9, 2026 |
| 2:00 PM - 3:30 PM |
| Tycho + Kepler |
Details
Global hepatitis C elimination strategies emphasise the need for community-centred and peer-led approaches to implementation. Yet, research on innovative harm reduction technologies and service designs for people who inject drugs often focus on whether they are ‘effective’, rather than how they are made to work in practice, and how they may be adapted to enhance their potential.
This session is grounded in implementation experiences from community-led, multi-country research to increase the uptake and use of low dead-space needles and syringes (LDSS) in low- and middle-income countries. The critical role of community-led research and peer-led knowledge mobilisation in supporting implementation and uptake of new harm reduction technologies in diverse contexts will be explored.
Audience members will be invited to reflect on country case studies, implementation tools, and broader perspectives from a diverse panel of experts and implementer and consider the implications for designing and implementing meaningful, community-responsive approaches that take advantage of prevention innovations across LMIC settings and beyond.
Speaker
Dr Annie Madden
Project Lead
International Network of People Who Use Drugs (INPUD)
Welcome
2:00 PM - 2:02 PMBiography
Mr Mat Southwell
Managing And Technical Director
Coact Technical Support LTD
Welcome
2:00 PM - 2:02 PMBiography
Dr Sophia Schroeder
Senior Research Officer
Burnet Institute
Enhancing the harm reduction potential of low-deadspace injecting equipment research in low- and middle-income countries
2:02 PM - 2:10 PMBiography
Mr. Aniedi Akpan
Executive Director
Drug Free And Prevention Healthcare Organisation (DAPHO)
Community-led values and preferences research for expanding uptake and use of LDSS: Nigeria
2:10 PM - 2:18 PMBiography
Angela McBride
Cab Member
HepC3P Global Community Advisory Board (CAB)
Community-led values and preferences research for expanding uptake and use of LDSS: South Africa
2:18 PM - 2:26 PMBiography
Zhenya Mayilyan
Chairwoman
Real World Real People Ngo
Community-led values and preferences research for expanding uptake and use of LDSS: Armenia
2:26 PM - 2:35 PMBiography
Mr Petik Yedigaryan
Autich
Real World Real People
Community-led values and preferences research for expanding uptake and use of LDSS: Armenia
2:26 PM - 2:35 PMBiography
Mr. Aniedi Akpan
Executive Director
Drug Free And Prevention Healthcare Organisation (DAPHO)
Panel Discussion
2:45 PM - 3:25 PMBiography
Prof Magdalena Harris
Professor Of Inclusion Health Sociology
London School Of Hygiene & Tropical Medicine
Panel Discussion
2:45 PM - 3:25 PMBiography
Zhenya Mayilyan
Chairwoman
Real World Real People Ngo
Panel Discussion
2:45 PM - 3:25 PMBiography
Angela McBride
Cab Member
HepC3P Global Community Advisory Board (CAB)
Panel Discussion
2:45 PM - 3:25 PMBiography
Mr Andrew Preston
Founder/Managing director
Exchange Supplies
Panel Discussion
2:45 PM - 3:25 PMBiography
Dr Sophia Schroeder
Senior Research Officer
Burnet Institute
Panel Discussion
2:45 PM - 3:25 PMBiography
Mr Petik Yedigaryan
Autich
Real World Real People
Panel Discussion
2:45 PM - 3:25 PMBiography
Dr Annie Madden
Project Lead
International Network of People Who Use Drugs (INPUD)
Where to from here?
3:25 PM - 3:30 PMBiography
Mr Mat Southwell
Managing And Technical Director
Coact Technical Support LTD
Where to from here?
3:25 PM - 3:30 PMBiography